Skip to main content

Table 2 Echocardiographic characteristics

From: Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study

Variables

Aortic coarctation (19 patients)

Controls (38 patients)

RA (38 patients)

LV End-diastolic diameter (ml/m2)

2.9 ± 0.3

2.3 ± 0.4 *

2.6 ± 0.3#

LV End-systolic diameter (ml/m 2)

1.9 ± 0.3

1.4 ± 0.4 *

1.7 ± 0.2#

LV End-diastolic volume (ml/m2)

66 ± 19

56 ± 12

51 ± 9 # §

LV End-systolic volume (ml/m2)

27 ± 9

21 ± 6

17 ± 4 # §

Relative wall thickness

0.35 ± 0.06

0.40 ± 0.07 *

0.43 ± 0.06 # §

Concentric LV geometry (%)

11

45 *

51 #

LV mass index (g/m 2.7)

41 ± 14

38 ± 13

38 ± 7#

LV hypertrophy (%)

37

20 *

6 # §

Inappropriate LV mass (%)

11

10

36 # §

LV stroke volume (ml)

73 ± 25

74 ± 18

59 ± 15 # §

Cardiac index (l/min/ m2)

2.7 ± 0.9

2.4 ± 0.7

2.3 ± 0.6#

LV ejection fraction (%)

60 ± 7

63 ± 5

65 ± 5#

LV CESS (dynes/cm2)

166 ± 49

128 ± 48 *

116 ± 28#

LV Sc- midwall shortening (%)

101 ± 15

98 ± 10

85 ± 11

Peak S’ (cm/sec)

7.1 ± 1.3

10.5 ± 3.6 *

10.2 ± 1.6#

Low peak S’ (%)

84

55 *

27# §

Peak E’ (cm/sec)

10.6 ± 3.5

12.3 ± 1.7

13.6 ± 2.2

E wave of transmitral flow (cm/sec)

103 ± 16

86 ± 19 *

75 ± 17# §

A wave of transmitral flow (cm/sec)

69 ± 25

64 ± 16

62 ± 15

E / A ratio

1.4 ± 0.36

1.4 ± 0.24

1.3 ± 0.40#

E / E’ ratio

10.5 ± 3.6

7.5 ± 2.3 *

5.6 ± 1.1# §

LV diastolic dysfunction (%)

11

2 *

3#

Maximal left atrial volume (ml/ m2)

27 ± 11

23 ± 11

18 ± 4

Aortic stiffness index (%)

9.8 ± 12.6

3.1 ± 2.0 *

4.8 ± 2.5#

Abnormally high aortic stiffness (% of patients)

26

10

21

  1. CESS circumferential end-systolic stress, LV left ventricular; Peak E’early diastolic Tissue Doppler velocity of mitral annulus, Peak S’ peak mitral annular systolic velocity (Tissue Doppler Imaging), RA rheumatoid arthritis, Sc stress corrected
  2. * = p < 0.05 controls vs coarctation;
  3. #= p < 0.05 rheumatoid arthritis vs coarctation;
  4. § = p < 0.05 rheumatoid arthritis vs controls